Establishing secure connection…Loading editor…Preparing document…

Healthcare Patient Study Consent Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE PATIENT STUDY CONSENT FORM

Study Title:

Principal Investigator:    Institution / Sponsor:

Patient Information

Patient Name:

Female    Male    Other / Prefer not to say

Insurance Information

Medical History

I am able to become pregnant or am currently pregnant / breastfeeding
I have an implanted device (e.g., pacemaker, neurostimulator)
I am immunocompromised or on immunosuppressive therapy

Study Procedures, Risks, and Benefits

I acknowledge that the Principal Investigator has explained the reasonably foreseeable risks, discomforts, and potential benefits associated with this study. I understand that risks may include, but are not limited to, physical injury, allergic reaction, emotional distress, loss of privacy, and unknown risks that cannot be anticipated. I have had the opportunity to ask questions about risks and receive answers.

I acknowledge that potential benefits may include contributions to medical knowledge, possible direct medical benefit, or no direct benefit. No guarantee of benefit has been made.

Confidentiality and Use of Health Information

My medical records and information collected for this study may be reviewed by study staff, monitors, the sponsor, and regulatory authorities for purposes of oversight and safety. Reasonable efforts will be made to protect my confidentiality. Identifiable information may be used for study conduct and monitoring, and de-identified data may be used for future research and publication.

I consent to the collection, use, and disclosure of my protected health information (PHI) as described in this form for purposes of this research study. This authorization expires on:

I consent to the following (select all that apply):
Use of de-identified data for future research and publication
Audiotaping or videotaping during study procedures if required
Collection and storage of biological samples for analysis and future research

Compensation, Costs, and Treatment for Injury

Compensation for participation, if any, and any costs or reimbursements are described below. There is no guarantee of payment for study-related injury. Medical treatment for direct injury resulting from study procedures will be provided as described; the availability of compensation and payment for treatment is further described below.

Voluntary Participation and Withdrawal

My participation in this study is voluntary. I may refuse to consent or may withdraw from the study at any time without penalty, loss of benefits to which I am otherwise entitled, or effect on my medical care. If I withdraw, I will inform the study staff and arrangements will be made concerning the handling of data and samples already collected.

I acknowledge that the following alternatives to participation were explained to me, including receiving standard medical care outside of the study.

Questions and Contacts

Consent and Authorization

By signing below, I certify that I have read (or someone has read to me) the information in this document, that the study has been explained to my satisfaction, that my questions have been answered, and that I voluntarily agree to participate in this research study. I understand that I will receive a copy of this Consent Form.

I authorize the use and disclosure of my protected health information as described above. I understand that I may revoke this authorization at any time by delivering a written revocation to the Principal Investigator, except to the extent that action has already been taken in reliance on this authorization.

Patient Printed Name:

Signature:

Date:

I have been given the opportunity to ask questions and have received satisfactory answers. I understand that participating is voluntary and that I may withdraw at any time.

Enter text✕

What the Healthcare Patient Study Consent Form Is

A Healthcare Patient Study Consent Form documents a participant's informed agreement to join a clinical or observational study. It explains study purpose, procedures, potential risks and benefits, confidentiality protections, data use, and participant rights including withdrawal. The form establishes legal and ethical consent required by Institutional Review Boards (IRBs) and applicable federal rules (for example, 45 CFR Part 46 for human subjects protections). Properly completed consents create a dated record that investigators, sponsors, and regulators rely on for compliance and patient safety.

Why a Clear, Complete Consent Form Matters

A well‑crafted consent protects participant autonomy, documents legal authorization, and supports IRB and regulatory compliance.

Why a Clear, Complete Consent Form Matters

Who Completes and Signs This Consent

Typical signers and administrative users who interact with the consent form.

  • Study participants or their legally authorized representatives who give informed consent to enroll in the study.
  • Principal investigators and study staff who obtain consent, document the process, and keep records.
  • IRB administrators and sponsors who review, approve, and retain the final signed consent documents.

Roles above are often coordinated: investigators obtain consent, IRBs approve language, and sponsors retain signed records for audits.

Step-by-Step: How to Complete the Consent Form

Follow a consistent sequence to collect the consent accurately and preserve evidence of informed choice.

  • 01
    Verify Eligibility: Confirm participant meets inclusion criteria before presenting consent.
  • 02
    Explain Study: Read or review procedures, risks, and benefits in plain language.
  • 03
    Answer Questions: Allow time for questions and document answers given.
  • 04
    Sign and Record: Collect dated signatures and provide the participant with a copy.

Essential Sections to Include in a Professional Consent

A complete consent form addresses study details, participant protections, and administrative logistics so signatures are legally defensible and ethically sound.

Study Purpose

Clearly describe objectives and why the participant is being invited. Avoid technical jargon and state the voluntary nature of participation to support informed decision making.

Procedures

List procedures, visit schedule, and time commitments. Include what is routine care versus research procedures and note any use of placebos or randomization.

Risks and Benefits

Explain reasonably foreseeable risks and potential benefits. Include both direct and indirect outcomes and alternative treatment options if applicable.

Confidentiality

Describe how data will be stored, who will see it, HIPAA protections if PHI is used, and any plan for data sharing or future use of specimens.

Voluntary Participation

State that participation is voluntary, that refusal won't affect care, and provide withdrawal procedures and consequences for data already collected.

Contact Information

Provide investigator, IRB, and emergency contact details so participants can obtain answers or report concerns at any time.

Data and Security Items to Record

Participant ID: Unique study identifier
Signature Date: MM/DD/YYYY
Signer Role: Participant or LAR
Witness Name: If required
Consent Version: Protocol version/date
Access Controls: Who can view PHI

How to Configure an Online Consent Workflow

Set up fields, authentication, and routing so digital signatures meet legal and IRB requirements.

Field Configuration
Authentication Level Email link or SMS code; stronger MFA for sensitive studies
Required Fields Make signature, date, and participant name mandatory
Conditional Logic Show guardian fields when participant is a minor
Retention Settings Enable audit trail and exportable PDF with metadata

Digital Signing: Technical and Compliance Considerations

Choose a platform that supports secure authentication, audit trails, and HIPAA controls when PHI is involved.

  • Authentication: Support email links, SMS codes, or stronger verification
  • Audit Trail: Capture timestamps, IP addresses, and user actions
  • HIPAA Support: Business Associate Agreement available if storing PHI

Typical eConsent Process Flow

An eConsent workflow should be simple for participants while preserving a robust record for compliance and audits.

  • Upload Consent: Upload final IRB‑approved PDF or template
  • Place Fields: Add signature, initials, and date fields
  • Invite Signer: Send secure link or email invitation
  • Store Record: Save signed PDF plus audit trail

Key Timing Rules and Expectations

Timing requirements focus on when consent must be obtained, when copies are provided, and when records must be retained.

Before Procedures:

Consent must be documented before any study procedures not part of standard care

Copy to Participant:

Provide signed copy at or shortly after signing

Version Control:

Use the IRB‑approved consent version current at enrollment

Withdrawal Requests:

Honor withdrawal requests promptly and document the effective date

Regulatory Reporting:

Report consent‑related serious issues per IRB and sponsor timelines

Milestones in the Consent Lifecycle

Track major stages from draft approval through long‑term retention so responsibilities and timelines are clear.

01

IRB Approval

IRB approves consent language and version control is locked.

02

Enrollment

Participant signs consent and enrollment is recorded.

03

Ongoing Oversight

Monitor consent compliance and report deviations to IRB.

04

Archival

Move signed consents to secure long‑term storage per record retention policy.

Common Mistakes to Avoid

  • Using an outdated IRB version of the consent instead of the current approved template, causing noncompliance and rework.
  • Failing to record the signer’s role (participant versus legally authorized representative), which creates ambiguity in authorization.
  • Omitting required witness or interpreter entries for participants who need assistance, undermining validity of consent.
  • Not securing a copy of the signed consent for both participant and study records, risking audit findings and participant disputes.

Risks and Consequences of Improper Consent

Invalid Consent: Study data may be unusable
Regulatory Action: IRB sanctions or study suspension
HIPAA Violation: Potential civil penalties under HIPAA
Liability Exposure: Legal claims from participants
Data Loss: Inability to use collected data
Reputational Harm: Loss of trust for researchers and sponsors

eSignature Vendor Comparison for Healthcare Consents

Basic pricing and capability highlights to consider for eConsent workflows; signNow appears first for parity in comparison.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day trial Varies by vendor Varies by vendor Varies by vendor Varies by vendor
Bulk Send Yes Yes Yes Yes Limited
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Frequently Asked Questions About eConsent and Signatures

Answers to common questions about legality, withdrawals, authentication, and recordkeeping for patient study consent forms.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users